Prospect Park Capital Corp. (TSXV:PPK.P) entered into an agreement to acquire stake in Skyline Medical Inc. (OTCPK:SKLN) from SOK Partners LLC for CAD 1 million in cash and stock on September 25, 2013. Under the terms, Prospect will pay CAD 0.4 million at closing, issue its 1.3 million shares and issue 1.7 million shares 6 months after closing of the transaction. In related transactions, Prospect Park Capital also agreed to acquire JB Therapeutics, Inc. and IOI, LLC. The transaction is subject to completion of certain conditions precedent, including, satisfactory due diligence, execution of definitive agreements and receipt of all necessary director, shareholder, regulatory and Exchange approvals. The transaction was conditionally approved by exchange on August 28, 2014. The shareholder meeting of Prospect Park will be held on September 25, 2014. As on September 9, 2014, Prospect Park Capital Corp. (TSXV:PPK.P) entered into a share purchase agreement to acquire stake in Skyline Medical Inc. (OTCPK:SKLN) from SOK Partners LLC.

Prospect Park Capital Corp. (TSXV:PPK.P) completed the acquisition of unknown stake in Skyline Medical Inc. (OTCPK:SKLN) from SOK Partners LLC on October 23, 2014.